Stocks to sell

Although Gevo (NASDAQ:GEVO) made a few positive deals recently and it could benefit from multiple government initiatives, the company is still facing difficult hurdles. Moreover, the valuation of GEVO stock remains elevated, given the company’s uncertain outlook. Source: Scharfsinn / Shutterstock.com As a result of the company’s challenges and weaknesses, along with its high valuation,

Buying stocks on dips can sometimes be a profitable strategy. However, grabbing shares of Paysafe (NYSE:PSFE) could be harmful to your fiscal health, as PSFE stock has entered into a harsh and persistent bear market. Source: Sulastri Sulastri / Shutterstock.com If you abide by the principle of “the trend is your friend,” then there’s nothing

With Thanksgiving and other winter holidays fast approaching, it’s a good practice to stop and consider what we’re grateful for. When it comes to the professional realm, I’m appreciative for the ability to get paid for crafting (hopefully) compelling stories. Through this journey, I’ve reached out to millions and even make regular TV appearances. But

There is little leg room remaining in Lucid (NASDAQ:LCID) stock. Shares of the electric vehicle (EV) manufacturer have been up 86.4% in the last month. That makes it firmly overvalued.  Source: Around the World Photos / Shutterstock.com The electric car has been the go-to for people looking to make their carbon footprint smaller. EV technology

Exela Technologies (NASDAQ:XELA) reported lackluster third-quarter results earlier this month. The business process automation firm saw a steep decline in revenue growth and missed analyst expectations on both lines by a fair margin. To make matters worse, is it has a burgeoning debt load. All together, this makes XELA stock a remarkably risky investment. Source:

QuantumScape (NYSE:QS) is back on the upswing. After a difficult year for QS stock, shares have doubled in recent weeks. The stock is still down sharply from its old highs, but at least shareholders have some reason for optimism. Source: Michael Vi/Shutterstock.com There are two things powering up QuantumScape here. For one, the company announced

IonQ (NYSE:IONQ) has been on a run. IONQ stock doubled in November. Heading into the company’s third-quarter results, it appeared that the stock’s momentum might dampen a bit following the earnings release. Source: Shutterstock The company announced its quarterly results on Nov. 15. Not surprisingly, given its startup status, IonQ generated a mere $223,000 of

Ford Motor (NYSE:F) stock is up more than 100% year-to-date, but people still don’t seem to believe in it as an electric car company. Source: Proxima Studio / Shutterstock.com Lucid Group (NASDAQ:LCID), which just delivered its first car, is the latest electric start-up to pass Ford in market cap. Before that Rivian (NASDAQ:RIVN) did it,

I continue to believe that Remark (NASDAQ:MARK) stock has vast amounts of potential. But with the company seemingly having difficulty converting that huge potential into revenue and profits, investors should move to the sidelines for now. Source: Phonlamai Photo / Shutterstock.com Also worth noting is that the company, to my knowledge, has not articulated a

Shares of Lucid Group (NASDAQ:LCID) sold off today, falling more than 10% as investors took profits. Yet, LCID stock still has a ludicrous market cap of more than $76 billion. Source: ggTravelDiary / Shutterstock.com That puts the electric vehicle startup on par with some of the biggest U.S. automakers. Ford Motor (NYSE:F) and General Motors (NYSE:GM),

“The Great Resignation” has suddenly come to the forefront. Economists and political commentators are using it broadly to make a variety of points about business, labor conditions and society at large. This can be confusing, however, as many people are trying to use the newly-emerging concept to push their own preferred narrative. So let’s start

Rivian (NASDAQ:RIVN) is yet another example of the current retail investing revolution. With hot trends like electric vehicle (EV) stocks still top of mind, there has been a continuous struggle between small-time investors and institutional players. What’s more, Rivian has already delivered a ton of excitement to believers, sporting gains of 120% from its initial

At just above $11.20 per share, BlackBerry (NYSE:BB) has held onto a decent chunk of its 2021 meme stock gains. The question now is whether that will stay the case for BB stock once the meme stock phenomenon finally comes to an end. Source: Paul McKinnon/Shutterstock.com My colleagues here at InvestorPlace are split on its

In recent days, Ocugen (NASDAQ:OCGN) has been a source of windfall profits for both fast-money retail traders and the stock’s deeply entrenched bear camp. But for less fleet-footed investors, it’s likely time to move on from OCGN stock. Let me explain. Source: shutterstock.com/PhotobyTawat Reddit’s excessive influence on a subset of companies’ shares has been a

You can make money playing penny shares like Progenity (NASDAQ:PROG) stock. Just get out while the getting is good. Source: PopTika / Shutterstock.com Progenity stock has been subject to a short squeeze since late September when it was selling below $1/share. It opened Nov. 16 at almost $4. As of late October, about 14% of

GameStop (NYSE:GME) stock is pulling back after its recent surge. But by-and-large, not much has changed for it. As with AMC Entertainment (NYSE:AMC), a core base of retail traders (“Apes,” as they sometimes call themselves) continue to hold onto their GME stock. Source: Shutterstock / mundissima To keep these investors happy and to remain in

Barron’s reported on Nov. 8 that the New York State Teachers’ Retirement System sold 13,601 shares of GameStop (NYSE:GME) stock in the third quarter Source: quietbits / Shutterstock.com Fear not, meme-stock lovers. The pension fund still owns 61,150 shares of GME stock. According to WhaleWisdom.com, GameStop is the pension fund’s 532nd-largest holding, so it’s clearly

BlackBerry’s (NYSE:BB) lackluster operating performance indicates that it is unlikely to create long-term value. Though one of its core products, QNX, continues to gain traction, it’s hardly enough to generate meaningful returns for the company. Moreover, with its management’s spotty track record, it seems improbable that they would wisely allocate the proceeds from the sale

Ocugen (NASDAQ:OCGN) has been one of 2021’s most volatile biotech companies. OCGN stock spiked from $2 to above $10 back in February after Ocugen announced that it was partnering with India’s Bharat Biotech on the latter’s Covid-19 vaccine.   Since then, Ocugen has been a roller coaster, dipping to $7 or $8 repeatedly before spiking up

Lucid Motors (NASDAQ:LCID) stock has some very impressive strengths, including the resume of its CEO and the positive reviews and  unmatched range of its Lucid Air electric vehicle. Source: Around the World Photos / Shutterstock.com These advantages, along with a large amount of press coverage, explain the current, gigantic valuation of LCID stock. That huge